MI:RNA Diagnostics

Wishing you a Merry Christmas from MI:RNA Diagnostics. To all the amazing veterinary professionals who dedicate themselves to the health and well-being of animals, and to everyone else who has supported us this year, we extend our warmest holiday wishes. As we celebrate this festive season, we take a moment to reflect on the accomplishments of 2024 and look forward to an exciting 2025.  

Earlier this month, our CEO and founder Eve Hanks attended the Pet Connect conference in Los Angeles, an event that never fails to amaze us with its creativity and innovation in the animal health space. From groundbreaking med-tech advancements to unique ventures like dog astrology, the conference showcased the incredible range of ideas shaping the future of our industry. One of the most valuable aspects of this trip was the opportunity to connect with investors and strategic partners. Building strategic relationships is vital to propel MI:RNA Diagnostics’ mission to transform animal health through cutting-edge microRNA diagnostics. It’s events like these that remind us why we do what we do—and what’s possible when innovation meets purpose. 

Read all about it! Have you spotted us in the news recently? Last week Robert Coultous, our CSO and co-founder, was profiled in dvm360® discussing mitral valve disease and how our microRNA-based technology has demonstrated its ability to detect this common disease in dogs earlier than conventional techniques. “Our research marks a significant advance in personalised veterinary care and diagnostic techniques. By identifying this disease before symptoms arise, we’re empowering veterinarians with a valuable tool to intervene early.” https://lnkd.in/eFHtGKFq 

Read all about it! Have you spotted us in the news recently? Last week Robert Coultous, our CSO and co-founder, was profiled in dvm360® discussing mitral valve disease and how our microRNA-based technology has demonstrated its ability to detect this common disease in dogs earlier than conventional techniques. “Our research marks a significant advance in personalised veterinary care and diagnostic techniques. By identifying this disease before symptoms arise, we’re empowering veterinarians with a valuable tool to intervene early.” https://lnkd.in/eFHtGKFq 

Today is International Day of Veterinary Medicine.  We recognise the incredible dedication and expertise of veterinary professionals worldwide who work tirelessly to protect and improve animal health. Our roles are critical—not only in ensuring the well-being of pets and farmed animals but also in advancing research and innovation for a healthier and more sustainable future. At MI:RNA Diagnostics, we are proud to collaborate with veterinarians and researchers to bring cutting-edge diagnostic tools, like our microRNA technology, to the forefront of animal care. Together, we’re driving progress in early disease detection, personalised treatments, and better health outcomes for animals everywhere. Thank you to all veterinary professionals for your invaluable contributions. 

MI:RNA team members attended the excellent "Action Johne's Conference: Taking the Next Steps", held in Worcester last week. The launch of Phase III of the Action Johne’s Initiative was centerstage. Vets, farmers, milk purchasers and a range of industry representatives had the opportunity to discuss the management of the disease, and appreciate the progress achieved so far and the challenges going forward. Here at MI:RNA, we are committed to the challenge of enhancing diagnosis and disease management: "Stopping the Tap" at the source of infection in the first instance. https://lnkd.in/gHcrZjWS 

The Virtual Veterinary Conference is back for its fourth edition on Saturday 7th December at 10am. This year, we’ll explore the range of conditions dogs and cats experience throughout their lives. Topics include dermatology, cardiology, behaviour, osteoarthritis, nutrition, offering valuable insights for both veterinarians and veterinary nurses. We’re pleased to announce that our founder Eve Hanks is one of the featured speakers. Join us for this engaging virtual event. https://lnkd.in/eNNMBRDN 

At MI:RNA we are revolutionising disease detection by integrating ground-breaking biomarker technology with a sophisticated AI platform to enable early diagnosis. Our predictive models are created by a team of world-class experts. Javier Palarea-Albaladejo, our AI Lead, brings over 25 years of expertise in statistical modelling and interdisciplinary data analysis, ensuring our platform remains at the cutting-edge. Paul Capewell, molecular genetics and bioinformatics expert, leverages his experience in academia and industry to develop tools that enhance precision medicine.     Our team of experts play a crucial role in animal healthcare practices, offering renewed hope to pet owners, farmers, and the wider veterinary community. 

A couple of months ago we hosted a webinar on tackling Johne’s Disease, one of the biggest challenges for cattle farmers. Today, Huw, Rob, Harry and Sian from our team join the Action Johne’s Conference in Worcester to learn more about the next steps in tackling this disease. Our team attended presentations, learned about existing case studies and networked with experts in the fight against Johne’s Disease, coming home with new insights into how we can contribute to research and development in this field.  

Last week some of our team attended the London Vet Show & BVA Live. The team had a fantastic experience connecting with industry leaders, potential investors, and distributors. We also deepened relationships with our partner laboratories, explored exciting collaborations, and engaged in great discussions with the press. It was a great couple of days of innovation, teamwork, and inspiring conversations, and we’re excited about the opportunities ahead.